CareDx Price to Sales Ratio 2013-2026 | CDNA
Historical PS ratio values for CareDx (CDNA) over the last 10 years. The current P/S ratio for CareDx as of June 05, 2026 is .
| CareDx P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2026-06-08 | 21.95 | 2.85 | |
| 2026-03-31 | 17.36 | $7.71 | 2.25 |
| 2025-12-31 | 18.84 | $7.02 | 2.68 |
| 2025-09-30 | 14.54 | $6.52 | 2.23 |
| 2025-06-30 | 19.54 | $6.22 | 3.14 |
| 2025-03-31 | 17.75 | $6.40 | 2.78 |
| 2024-12-31 | 21.41 | $6.26 | 3.42 |
| 2024-09-30 | 31.23 | $5.95 | 5.25 |
| 2024-06-30 | 15.53 | $5.62 | 2.76 |
| 2024-03-31 | 10.59 | $5.16 | 2.05 |
| 2023-12-31 | 12.00 | $5.21 | 2.31 |
| 2023-09-30 | 7.00 | $5.53 | 1.27 |
| 2023-06-30 | 8.50 | $5.77 | 1.47 |
| 2023-03-31 | 9.14 | $5.98 | 1.53 |
| 2022-12-31 | 11.41 | $6.04 | 1.89 |
| 2022-09-30 | 17.02 | $6.01 | 2.83 |
| 2022-06-30 | 21.48 | $5.96 | 3.60 |
| 2022-03-31 | 36.99 | $5.87 | 6.30 |
| 2021-12-31 | 45.48 | $5.69 | 7.99 |
| 2021-09-30 | 63.37 | $5.43 | 11.66 |
| 2021-06-30 | 91.52 | $5.09 | 17.99 |
| 2021-03-31 | 68.09 | $4.60 | 14.79 |
| 2020-12-31 | 72.45 | $4.18 | 17.33 |
| 2020-09-30 | 37.94 | $3.77 | 10.06 |
| 2020-06-30 | 35.43 | $3.48 | 10.19 |
| 2020-03-31 | 21.83 | $3.29 | 6.63 |
| 2019-12-31 | 21.57 | $3.02 | 7.15 |
| 2019-09-30 | 22.61 | $2.83 | 7.99 |
| 2019-06-30 | 35.99 | $2.60 | 13.84 |
| 2019-03-31 | 31.52 | $2.36 | 13.38 |
| 2018-12-31 | 25.14 | $2.21 | 11.40 |
| 2018-09-30 | 28.85 | $2.08 | 13.86 |
| 2018-06-30 | 12.24 | $2.05 | 5.96 |
| 2018-03-31 | 7.97 | $2.11 | 3.77 |
| 2017-12-31 | 7.34 | $2.18 | 3.36 |
| 2017-09-30 | 3.70 | $2.30 | 1.61 |
| 2017-06-30 | 1.11 | $2.40 | 0.46 |
| 2017-03-31 | 1.40 | $2.63 | 0.53 |
| 2016-12-31 | 2.70 | $2.64 | 1.02 |
| 2016-09-30 | 3.55 | $2.54 | 1.40 |
| 2016-06-30 | 4.31 | $2.50 | 1.72 |
| 2016-03-31 | 4.96 | $2.31 | 2.14 |
| 2015-12-31 | 6.40 | $2.38 | 2.69 |
| 2015-09-30 | 4.17 | $2.67 | 1.56 |
| 2015-06-30 | 6.50 | $2.66 | 2.44 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.822B | $0.380B |
| CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $134.187B | 24.31 |
| HCA Healthcare (HCA) | United States | $110.772B | 17.53 |
| CVS Health (CVS) | United States | $101.670B | 11.75 |
| Elevance Health (ELV) | United States | $68.432B | 10.33 |
| Cencora (COR) | United States | $62.409B | 19.63 |
| Natera (NTRA) | United States | $27.358B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.501B | 15.87 |
| DiDi Global (DIDIY) | China | $18.026B | 15.96 |
| Viatris (VTRS) | United States | $15.685B | 5.71 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.535B | 0.00 |
| Medpace Holdings (MEDP) | United States | $14.094B | 32.26 |
| BioMerieux (BMXMF) | France | $12.476B | 0.00 |
| Solventum (SOLV) | United States | $11.408B | 10.78 |
| Revvity (RVTY) | United States | $10.039B | 17.71 |
| BrightSpring Health Services (BTSG) | United States | $8.774B | 43.59 |
| Charles River Laboratories (CRL) | United States | $8.667B | 17.09 |
| ICON (ICLR) | Ireland | $8.626B | 8.56 |
| CochLear (CHEOY) | Australia | $8.030B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.905B | 0.00 |
| HealthEquity (HQY) | United States | $6.586B | 23.20 |
| Bausch + Lomb (BLCO) | Canada | $5.877B | 32.98 |
| GETINGE (GNGBY) | Sweden | $5.626B | 17.96 |
| Avantor (AVTR) | United States | $5.388B | 8.68 |
| PACS (PACS) | United States | $5.304B | 27.44 |
| Caris Life Sciences,�Inc (CAI) | United States | $5.101B | 0.00 |
| Sotera Health (SHC) | United States | $4.380B | 19.95 |
| Alignment Healthcare (ALHC) | United States | $4.188B | 0.00 |
| Concentras Parent (CON) | United States | $2.818B | 16.12 |
| Organon (OGN) | United States | $2.299B | 2.57 |
| Amplifon S.p.A (AMFPF) | Italy | $2.275B | 13.27 |
| Pediatrix Medical (MD) | United States | $1.782B | 11.11 |
| Establishment Labs Holdings (ESTA) | United States | $1.765B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.746B | 42.28 |
| Surgery Partners (SGRY) | United States | $1.671B | 41.65 |
| Sonida Senior Living (SNDA) | United States | $1.544B | 0.00 |
| Ardent Health (ARDT) | United States | $1.345B | 5.70 |
| Progyny (PGNY) | United States | $1.277B | 25.08 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.240B | 0.00 |
| InnovAge Holding (INNV) | United States | $1.113B | 164.00 |
| Teladoc Health (TDOC) | United States | $0.920B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.750B | 12.17 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| Nutex Health (NUTX) | United States | $0.704B | 11.25 |
| Omada Health (OMDA) | United States | $0.672B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.604B | 99.85 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.531B | 0.00 |
| Embecta (EMBC) | United States | $0.524B | 2.92 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.482B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.435B | 4.70 |
| SBC Medicals (SBC) | United States | $0.426B | 8.47 |
| Forward Industries (FWDI) | United States | $0.375B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.349B | 0.00 |
| Agilon Health (AGL) | United States | $0.316B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.309B | 0.00 |
| Oncology Institute (TOI) | United States | $0.304B | 0.00 |
| So-Young (SY) | China | $0.262B | 0.00 |
| LifeMD (LFMD) | United States | $0.166B | 0.00 |
| Biodesix (BDSX) | United States | $0.133B | 0.00 |
| Beauty Health (SKIN) | United States | $0.115B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.091B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.080B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.077B | 0.00 |
| DocGo (DCGO) | United States | $0.051B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Pomdoctor - (POM) | China | $0.031B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.026B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.015B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Lifeward (LFWD) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.005B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |